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The cycloaddition of acetylenes with azides to give the corresponding 1,4-disubstituted 1,2,3-triazoles is
reported using immobilised reagents and scavengers in pre-packed glass tubes in a modular flow reactor.
Introduction
In this and the following communication,1 we describe applica-
tions and further concepts for the use of modular continuous
flow reactor systems. These methods are gaining popularity for
the preparation of fine chemicals at the micro- and meso-fluidic
levels2 as well as for small-scale manufacturing production.3
Our own efforts in this area have focused on flow
hydrogenation,4 microwave-assisted flow chemistry5 and the use
of microfluidic chips together with pre-packed tubes containing
immobilised reagents and scavengers to effect the multi-step
synthesis of natural products,6 peptides7 and medicinally relevant
heterocyclic systems.8 The appropriate use of flow techniques
allows direct access to target compounds in high purity, avoiding
technically demanding and time consuming work-up and pu-
rification procedures common to conventional batch-chemistry
processes.
The pioneering work of Huisgen9 on the [3 + 2] cycloaddition
of acetylenic compounds with azides leading to 1,4-disubstituted
1,2,3-triazoles, followed by recent modifications by Mendal10 and
Sharpless (Click chemistry),11 has become an important strategy in
a variety of applications; including organic synthesis (Scheme 1),
material science and cell biology.12 In this paper, we report on the
use of a small footprint modular flow reactor to accomplish this
useful transformation on gram scale with a variety of acetylene
and azide building blocks. As reported in our previous com-
munications describing flow-chemistry applications,4–8 the flow
reactor and pumping system is based on a modified automated
HPLC unit and fraction collector. The work described herein was
carried out using the Syrris AFRICAR©13 flow pumping system, a
commercially available platform which can be readily adapted to
incorporate the necessary sequence of pre-packed flow columns
when combined with a Vapourtec R4R©14 column heater unit.
Scheme 1 Copper(I)-mediated 1,2,3-triazole formation.
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Results and discussion
Recently, Girard15 described the successful immobilisation of a
copper(I) iodide species to a solid support, an Amberlyst A-21
free base16 (PS–NMe2), and applied it as a catalyst in a batch-
mode cycloaddition reaction. Our own experiments under flow
conditions reported here also use a copper-modified Amberlyst A-
21 resin, which produces the highest loading resin (1.33 mmol g−1
bymass increase) whilst retaining the basic functionality necessary
for themechanism of the cycloaddition reaction.17 As the copper is
only attached to the resin by weak co-ordination to the amine lone
pair, the copper species is expected to leach to some extent into
the solution phase. Indeed this is confirmed by the blue or green
tinted solutions obtained when these reactions are run in batch
mode. This problem is easily solved by the use of QuadrapureTM
TU (QP-TU) metal-scavenging resin.18 Stirring the resin with the
batch solution results in complete removal of the colour from the
solution in less than 30 minutes (Scheme 2).
Scheme 2 Improved batch method.
Our initial investigations into a flow-based process revealed that
excess azide was required to drive the reaction to completion in
only a single pass through the flow reactor. The excess azide,
contaminating the triazole product, could be removed by flowing
the reaction solution through a column of phosphine resin (PS–
PPh2),19 thus capturing the azide onto the solid phase as an
iminophosphorane via a Staudinger reaction (Scheme 3).6b
In practice, the azide (0.15–0.2 M, 1.5–2 equiv.) and terminal
alkyne (1 equiv.) components are dissolved in DCM and injected
into a manual load reagent loop, which is connected in-line with
the flow system. Multiple reagent stores can be configured in
this way for successive iterative additions of different reagent
combinations. The contents of a particular reagent loop (typically
1 mL or 5 mL) are then introduced into the flow stream and
pumped through the columns containing the supported reagents,
generating the specified 1,2,3-triazole product.
Glass Omnifit R© columns20 containing the PS–NMe2, CuI com-
plex (0.1 equiv), QP-TU (100 mg) and then PS–PPh2 (3 equiv.) are
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Scheme 3 Outline of flow methodology.









1 93% 8 93%
2 85% 9 88%
3 85% 10 91%
4 91% 11 81%
5 89% 12 85%
6 87% 13 70%
7 75% 14 88%
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placed in series. The columns are prewashed with DCM, then the
reagent solution is introduced at 30 lLmin−1. After the calculated
time for the starting materials to have passed through all of the
columns has elapsed (time equivalent to filling the reagent loop
three times), the flow rate is increased to 250 lL min−1 to elute
the product from the columns. A back-pressure regulator was
placed in-line at the exit of the flow stream and set to ∼7 bar (100
psi) to ensure a uniform flow stream. The resulting solution was
then concentrated using a Vapourtec V-10R© solvent evaporator,21
providing a solid product ready for analysis. Following this
procedure, the products in Table 1 were obtained without the need
for further purification; all purities were assessed as being >95%,
as determined by LC-MS and 1H- and 13C-NMR.
Normally the flow reactions were operated to deliver 20–200mg
of product; however in one experiment 1.5 g of the triazole (entry 2,
Table 1) was produced as a continuous flow process after 3 hours.
This modified process used 2 equiv. of propargylic alcohol, 400mg
of PS–NMe2. CuI and 200 mg of QP-TU, and was flowed at
100 lL min−1, followed by washing at 250 lL min−1. The excess
propargylic alcohol was removed in vacuo, to give the product in
85% yield and >95% purity.
In addition to the potential scalability demonstrated above, this
continuous flow system has additional advantages over conven-
tional batch procedures for the preparation of 1,2,3-triazoles. For
example, both the acetylenes (prepared via a Sonogashira reac-
tion), and the azides6b can be generated in-line by flow-chemistry
methods. From a safety view point, this ability to form and trap
reactive intermediates in-line without manual intervention by the
chemist reduces their exposure to such potentially explosive and
highly toxic chemical inputs.
Furthermore, the nature of the flow process means that the
reactants are exposed to a much higher apparent concentration of
the copper catalyst, allowing reduced catalyst loading. Finally, due
to the very short residence/reaction times and the easy exclusion
of oxygen from the system, Glaser homocoupling, a common side
reaction in this type of synthesis, is prevented ensuring that the
products require no further purification.
Conclusion
In conclusion, the application of a modular flow reactor to
the continuous preparation of 1,4-disubstitued 1,2,3-triazoles
described above illustrates further the potential of these systems
for the on-demand preparation of chemical substances.
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